Brisco, M. A., Zile, M. R., Hanberg, J. S., Wilson, F. P., Parikh, C. R., Coca, S. G., … Testani, J. M. (2016). Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. Journal of Cardiac Failure, 22(10), 753–760. https://doi.org/10.1016/j.cardfail.2016.06.423

Brisco, Meredith A., Michael R. Zile, Jennifer S. Hanberg, F Perry Wilson, Chirag R. Parikh, Steven G. Coca, WH Wilson Tang, and Jeffrey M. Testani. “Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.” Journal of Cardiac Failure 22, no. 10 (October 2016): 753–60. https://doi.org/10.1016/j.cardfail.2016.06.423.

Brisco MA, Zile MR, Hanberg JS, Wilson FP, Parikh CR, Coca SG, et al. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. Journal of Cardiac Failure. 2016 Oct;22(10):753–60.

Brisco, Meredith A., et al. “Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.” Journal of Cardiac Failure, vol. 22, no. 10, Elsevier BV, Oct. 2016, pp. 753–60. Crossref, doi:10.1016/j.cardfail.2016.06.423.

Brisco MA, Zile MR, Hanberg JS, Wilson FP, Parikh CR, Coca SG, Tang WHW, Testani JM. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. Journal of Cardiac Failure. Elsevier BV; 2016 Oct;22(10):753–760.